Keyphrases
Interferon-α (IFN-α)
100%
Chronic Hepatitis C
100%
Clinical High Risk
100%
Psychological Risk
100%
Major Depressive Disorder
60%
Citalopram
60%
Persons with Mental Illness
60%
Antidepressants
40%
Infected Patients
40%
Patient Demographics
20%
Antiviral Treatment
20%
Ribavirin
20%
Hepatitis C Treatment
20%
IFN Therapy
20%
Double-blind Placebo-controlled Trial
20%
DSM-IV
20%
Prophylactic Treatment
20%
Psychiatric Patients
20%
Preemptive Treatment
20%
Psychiatric Care
20%
Antidepressive Treatment
20%
Antidepressant Therapy
20%
Pegylated Interferon alfa-2a
20%
Psychiatric Risk Factors
20%
Nursing and Health Professions
Alpha Interferon
100%
Chronic Hepatitis C
100%
Major Depression
75%
Patient with Psychiatric Disorder
75%
Citalopram
75%
Antidepressant
75%
Pilot Study
25%
Patient Population
25%
Placebo
25%
Mental Health Care
25%
DSM-IV
25%
Hepatitis C
25%
Peginterferon Alpha2b
25%
Alpha2b Interferon Plus Ribavirin
25%
Antiviral Therapy
25%
Efficacy
25%
Neuroscience
Interferon Alfa
100%
Hepatitis C
100%
Mental Disorder
75%
Major Depressive Disorder
75%
Citalopram
75%
Antidepressant
50%
Antidepressant Therapy
25%
Placebo
25%
Alpha2b Interferon Plus Ribavirin
25%
Peginterferon Alfa-2b
25%
Risk Factor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Hepatitis C
100%
Alpha Interferon
100%
Antidepressant
75%
Major Depression
75%
Citalopram
75%
Placebo
25%
Antivirus Agent
25%
DSM-IV
25%
Hepatitis C
25%
Peginterferon Alpha2b
25%
Alpha2b Interferon Plus Ribavirin
25%
Psychology
Major Depressive Disorder
100%
Major Depression
100%
Major Depressive Episode
100%
Antidepressant Therapy
33%